Color Doppler and hormone replacement therapy: The role of thromboxane and plasma viscosity

Gynecological Endocrinology

Volumn 13, Issue 3, 1999, Pages 183-188

  Battaglia, C ^a   Salvatori, M ^a   Callinelli, A ^a   Artini, P G ^b   Genazzani, A R ^b   Volpe, A ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Doppler; HRT; Plasma viscosity; Thromboxane; Ultrasound

Indexed keywords

ESTRADIOL; FOLLITROPIN; HORMONE; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; THROMBOXANE;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD VESSEL WALL; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; DEVICE; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTERNAL CAROTID ARTERY; PLASMA VISCOSITY; POSTMENOPAUSE; PRIORITY JOURNAL; PULSATILE FLOW; TRANSDERMAL DRUG ADMINISTRATION; UTERINE ARTERY;

EID: 0033007815     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599909167553     Document Type: Article

References (27)

1. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. J Am Med Assoc 1991;265:1861-7
2. Gordon T, Castelli WP, Hjortland MC, et al. Menopause and coronary heart disease: the Framingham Study. Ann Intern Med 1978;89: 157-61
3. Sullivan JM. Hormone replacement therapy and cardiovascular disease: the human model. Br J Obstet Gynecol 1996;103:59-67
4. Bush TL. The epidemiology of cardiovascular disease in postmenopausal women. Ann N Y Acad Sci USA 1990;592:263-71
5. Bourne TH, Hillard TC, Whitehead MI, et al. Oestrogen, arterial status and postmenopausal woman. Lancet 1990;95:581-8
6. De Zeigler D, Bessis R, Frydman R. Vascular resistance of uterine arteries: physiological effects of oestradiol and progesterone. Fertil Steril 1991; 55:775-9
7. Horwitz KB, Horwitz LD. Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. J Clin Invest 1982;69:750-8
8. Mijatovic V, Pines A. Menopause-induced changes in cardiovascular functions and HRT. Eur Menopause J 1995;2:4-9
9. Hillard TC, Crayford TB, Bourne TH, et al. Differential effects of transdermal estradiol and sequential progestogens on impedence to flow within the uterine arteries of postmenopausal women. Fertil Steril 1992;58:959-64
10. Penotti M, Farina M, Sironi L, et al. Cerebral artery blood flow in relation to age and menopausal status. Obstet Gynecol 1996;88:106-9
11. Gangar KF, Vyas S, Whitehead MI, et al. Pulsatility index in the internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991;338:839-42
12. Belfort MA, Saade GR, Snabes M, et al. Hormonal status affects the reactivity of the cerebral vasculature. Am J Obstet Gynecol 1995;172:1273-9
13. Moncada S, Vane JR. Arachidonic acid metabolites and the interactions between platelets and blood vessel walls. N Engl J Med 1979;300:1142-6
14. Balteskard L, Brox JH, Osterud B. Thromboxane production in the blood of women increases after menopause whereas tumor necrosis factor is reduced in women compared with men. Atherosclerosis 1993;102:91-8
15. Luzi G, Coata G, Cucchia GC, et al. Doppler study of uterine arteries in spontaneous and artificially induced menopausal women. Ultrasound Obstet Gynecol 1993;3:354-6
16. Nastri MN, Shepherd JH, Setchell ME, et al. Sonographic depiction of postmenopausal endometrium with transabdominal and transvaginal scanning. Ultrasound Obstet Gynecol 1991;1:279-83
17. Lizzi FL, Mortimer AJ. Bioeffects considerations for the safety of diagnostic ultrasound. J Ultrasound Med 1988;7:1-38
18. Battaglia C, Artini PG, Bencini S, et al. Doppler analysis of uterine blood flow changes in spontaneous and medically induced menopause. Gynecol Endocrinol 1995;9:143-8
19. Battaglia C, Artini PG, D'Ambrogio G, et al. Uterine and ovarian blood flow measurement. Does the full bladder modify the flow resistance? Acta Obstet Gynecol Scand 1994;73:716-18
20. Battaglia C, Artini PG, Ballestri M, et al. Hemodynamic, hematological and hemorrheological evaluation of post-term pregnancy. Acta Obstet Gynecol Scand 1995;74:336-40
21. Pines A, Fiwsman EZ, Averbuch M, et al. The effects of hormone replacement therapy in normal postmenopausal woman: measurements of Doppler derived parameters of aortic flow. Am J Obstet Gynecol 1991;164:806-12
22. Still JG, Greiss FC. The effect of prostaglandins and other vasoactive substances on uterine blood flow and myometrial activity. Am J Obstet Gynecol 1978; 130:1-8
23. Balteskard L, Brox JH, Osterud B. Thromboxane production in the blood of women increases after menopause whereas tumor necrosis factor is reduced in women compared with men. Atherosclerosis 1993;102:91-8
24. Aune B, Oian P, Omsjo I, et al. Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood - A beneficial effect on atherogenesis and thrombus formation? Am J Obstet Gynecol 1995;1:1816-20
25. Kimura T, Yoshida Y, Toda N. Mechanisms of relaxation induced by prostaglandins in isolated canine uterine arteries. Am J Obstet Gynecol 1992; 176:1409-16
26. Meilahn EN, Kuller LH, Matthews KA, et al. Hemostatic factors according to menopausal status and use of hormonal replacement therapy. Ann Epidemiol 1992;2:445-55
27. Nablusi AA, Folsom AR, White A, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The atherosclerosis risk in communities study investigators. N Engl J Med 1993;328: 1069-75